Tag Archives: Potentially Inappropriate Prescribing (PIP)

Antidepressants Not Recommended for Depression in People With Dementia (NIHR Signal / Cochrane Database)

Posted on January 12, 2019 by Dementia and Elderly Care News

Summary A National Institute for Health Research “Signal” expert commentary refers to a systematic review which indicates that antidepressants are unsuitable / unhelpful for the treatment of depression in persons living with dementia. Full Text Link Reference Antidepressants do not … Continue reading →

Posted in Acute Hospitals, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, NIHR, Person-Centred Care, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged Addenbrooke), Addenbrookes Hospital, Adverse Effects, Adverse Events, ALOIS: a Comprehensive Register of Dementia Studies, ALOIS: Cochrane Dementia and Cognitive Improvement's Specialized Register, ALOIS: the Cochrane Dementia and Cognitive Improvement Group, Antidepressants, Antidepressants for Agitation and Psychosis in Dementia, Antidepressants for Depression in Dementia, Antidepressants for Treating Depression in Dementia, Cambridge and Peterborough NHS Foundation Trust, Cambridge University Hospitals (Addenbrooke’s), Cochrane Database, Cochrane Database of Systematic Reviews, Cochrane Dementia and Cognitive Impairment Group, Cochrane UK, Department of Psychiatry: University of Cambridge, Drug Side-Effects, Inappropriate Medication, Inappropriate Prescribing, Later Life, Mental Health and Illness, National Institute for Health Research Signal, National Perinatal Epidemiology Unit (NPEU): University of Oxford, NIHR Signal, Older People’s Mental Health Service: Cambridge and Peterborough NHS Foundation Trust, Oxford Health NHS Foundation Trust, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing, Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Depression and Dementia, Preventable Adverse Events, Professor Martin Orrell, Professor Martin Orrell: Director of Institute of Mental Health at University of Nottingham; Division of Psychiatry and Applied Psychology: University of Nottingham, Psychotropic Drug Use (Antipsychotics Antidepressants Hypnotics Anxiolytics Anticonvulsants Antidementia Drugs), Reducing Inappropriate Prescribing of Antidepressants, Selective Serotonin Reuptake Inhibitors (SSRIs), University of Cambridge, University of Nottingham, University of Oxford | Leave a comment

Management of BPSD in Alzheimer’s Disease (International Psychogeriatrics)

Posted on August 5, 2018 by Dementia and Elderly Care News

Summary A recent review examines current and emerging treatments for Behavioural and Psychological Symptoms of Dementia (BPSD) in Alzheimer’s Disease. This research was first aired at the 2015 International Psychogeriatric Association Meeting. The consensus view is that non-pharmacological approaches are … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK | Tagged 2015 International Psychogeriatric Association Meeting, Agitation, Agitation and Aggression, Alternatives to Antipsychotic Drugs, Alternatives to Medication for Agitation, Antipsychotics in Elderly People with Dementia, Antipsychotics Limitation in Dementia, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural Alternatives to Antipsychotic Drugs, Behavioural and Psychological Symptoms of Dementia (BPSD), BPSD in Alzheimer’s Disease, BPSD: Behavioral and Psychological Symptoms of Dementia, Consensus Statements About Dementia, Delphi Consensus, Department of Psychiatry and Behavioral Sciences: Johns Hopkins Bayview, Department of Psychiatry: University of Michigan, Describe Investigate Create and Evaluate (DICE) Approach, Dextromethorphan / Quinidine (DM/Q: Nuedexta™), Dextromethorphan Hydrobromide-Quinidine Sulfate, Dextromethorphan-Quinidine, Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer’s Disease, Drugs for BPSD, Efﬁcacy of Music Therapy, International Psychogeriatric Association Meeting (2015), International Psychogeriatrics, Interventions for BPSD, Johns Hopkins University, Management of BPSD in Alzheimer’s Disease, Managing Agitation, Medical School: University of Exeter, Music Therapy, Music Therapy and Dementia, Music Therapy for BPSD, Neuropsychiatric Symptoms (NPS), Neuropsychiatric Symptoms in People With Dementia, Pimavanserin, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Advanced Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Program for Positive Aging, Reducing Agitation and Distress, Risperidone, United States, University of Exeter, University of Exeter Medical School, University of Michigan, USA | Leave a comment

Pharmacological Treatment of Agitation in Persons With Dementia (British Journal of Clinical Pharmacology)

Posted on April 17, 2018 by Dementia and Elderly Care News

Summary A systematic review and meta‐analysis of pharmaceutical treatments for alleviating agitation in dementia has been performed. Regarding the efficacy and treatment acceptability of these medications, it is reported that: “Risperidone, SSRIs as a class and Dextromethorphan / Quinidine demonstrated … Continue reading →

Posted in Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Pharmacological Treatments, Quick Insights, Systematic Reviews | Tagged Agitation, Agitation and Aggression, Antidepressants, Antidepressants for Agitation and Psychosis in Dementia, Antipsychotics in Elderly People with Dementia, Asian Centre for Evidence Synthesis in Population Implementation and Clinical Outcomes (PICO): Monash University Malaysia, Atypical Antipsychotics, Australia, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Problems, Behavioural Problems in People With Dementia, BPSD: Behavioral and Psychological Symptoms of Dementia, British Journal of Clinical Pharmacology, Center of Pharmaceutical Outcomes Research (CPOR): Naresuan University, Centre for Medicine Use and Safety: Monash University, Chulalongkorn University (Bangkok), Dementia-Related Agitation, Department of Clinical Pharmacy: Mahasarakham University, Department of Pharmacy Practice: Naresuan University, Department of Psychiatry: King Chulalongkorn Memorial Hospital, Dextromethorphan / Quinidine (DM/Q: Nuedexta™), Faculty of Medicine: Chulalongkorn University, Faculty of Pharmaceutical Sciences: Naresuan University, Faculty of Pharmacy and Pharmaceutical Sciences: Monash University, Haloperidol, Health and Well-being Cluster - Global Asia in the 21st Century (GA21) Platform: Monash University Malaysia, Interventions for BPSD, King Chulalongkorn Memorial Hospital, Kolling Institute of Medical Research: Royal North Shore Hospital, Mahasarakham University (Thailand), Malaysia, Managing Agitation, Medication-Related Risks, Medications: Best Usage, Medicines Optimisation, Monash University, Monash University Malaysia, Mood Disturbances, Naresuan University (Thailand), Neuroleptics, Neuropsychiatric Symptoms (NPS), Neuropsychiatric Symptoms in People With Dementia, Oxcarbazepine, Patient Safety, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Advanced Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Psychotropic Drugs, Psychotropic Medication, Psychotropic Prescribing, Reducing Agitation and Distress, Risperidone, Royal North Shore Hospital (Australia), School of Pharmacy: Monash University Malaysia, Selective Serotonin Reuptake Inhibitors (SSRIs), SSRIs: Selective Serotonin Reuptake Inhibitors, Systematic Reviews and Meta-Analyses, Thailand, University of Sydney | Leave a comment

Review of Non-Pharmacological Interventions for Dementia-Related Agitation: Including a Brief Analysis of the Risks and Benefits of Drug Treatments (Translational Psychiatry)

Posted on October 31, 2017 by Dementia and Elderly Care News

Summary A recently published literature review evaluates the best available evidence on the effectiveness of various non-pharmacological interventions for reducing dementia-related agitation. The author also briefly addresses current viewpoints on balancing the risks and benefits of pharmacotherapy in the management … Continue reading →

Posted in Acute Hospitals, Antipsychotics, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Local Interest, Management of Condition, Mental Health, Models of Dementia Care, New Cross Hospital, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Royal Wolverhampton NHS Trust, Royal Wolverhampton NHS Trust Authorial Affiliation, Systematic Reviews, UK, Universal Interest, Wolverhampton | Tagged ACADIA Pharmaceuticals, Agitation, Agitation and Aggression, Alternatives to Antipsychotic Drugs, Animal Assisted Therapy, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics Limitation in Dementia, Antipsychotics-Related Mortality Risks, Aromatherapy, Arts and Music in Dementia, Atypical Antipsychotics, Avanir Pharmaceuticals Inc (California), Behavioural Alternatives to Antipsychotic Drugs, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Problems, Behavioural Problems in People With Dementia, Behavioural Variant Frontotemporal Dementia (bvFTD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Carbamazepine, Citalopram, Citalopram for Agitation in Alzheimer's Disease: CitAD Trial, Cognitive Behavioral Therapy, Dementia-Related Agitation, Department of Medicine: Royal Wolverhampton NHS Trust, Describe Investigate Create and Evaluate (DICE) Approach, East Kent Hospitals University NHS Foundation Trust, Electroconvulsive Therapy for Agitation and Aggression in Dementia, Improving the Quality of Life for People With Dementia, Interventions for BPSD, Intra-Cellular Therapies, Medication-Related Risks, Medications: Best Usage, Medicines Optimisation, Memantine, Mirtazapine, Mood Disturbances, Multisensory Stimulation, Music Therapy, Music Therapy for BPSD, Music-Based Therapeutic Interventions, Nature Publishing Group, Neuroleptic Discontinuation, Neuroleptics, Neuropsychiatric Symptoms (NPS), Neuropsychiatric Symptoms in People With Dementia, Non-Pharmacological Management of Symptoms, Non-Pharmacological Treatments, Otsuka Pharmaceuticals Limited, Pharmacological Treatments, Potential Harms of Antipsychotic Use, Potentially Inappropriate Medications (PIM), Potentially Inappropriate Prescribing (PIP), Potentially Inappropriate Prescribing in Advanced Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Quetiapine, Reducing Inappropriate Use of Antipsychotics in Dementia, Risperidone, Simulated Presence Therapy (SPT), Simulated Presence Therapy for BPSD, Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms (TIME), Translational Psychiatry, Withdrawal of Neuroleptic Medications | Leave a comment

Potentially Inappropriate Prescribing for Older Persons: Revisited (APPG on Dementia / Newsmax / European Journal of Clinical Pharmacology)

Posted on October 9, 2017 by Dementia and Elderly Care News

Summary The All-Party Parliamentary Group on Dementia (APPG), back in 2008, asserted that perhaps half of dementia patients may be receiving inappropriate medications. While the extent to which this position may have changed in recent years is debatable, the allegation … Continue reading →

Scoping the Potential Role(s) of Community Pharmacists in Medication Management for Community-Dwelling People With Dementia (Health Expectations)

Posted on October 5, 2017 by Dementia and Elderly Care News

Summary A new article has appeared on the roles for community pharmacists in assisting people with dementia dwelling in the community, their informal carers – and health and social care professionals more widely – in achieving safer and more effective … Continue reading →

Posted in Antipsychotics, Commissioning, Community Care, Falls Prevention, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged Ability of Community Pharmacists to Limit Use of Antipsychotics Prescribed Inappropriately For BPSD, Aston Health Research and Innovation Cluster, Aston University, Birmingham (UK), Caregiving (Carers), Caring for Carers, Communication Between Community Pharmacists and Caregivers, Communication Between Community Pharmacists and GPs, Community Pharmacies, Community Pharmacists, Community Pharmacy, Community-Based Care, Community-Based Care for People With Dementia, Community-Based Interventions, Community-Based Services, Community-Based Support, Community-Centred Approaches, Community-Dwelling Older People with Dementia, Dementia Friendly Community Pharmacists, Dementia-Friendly Businesses, Dementia-Friendly Cities, Dementia-Friendly Communities, Dementia-Friendly Community Pharmacies, Dementia-Friendly Information, Dementia-Friendly Neighbourhoods, Dementia-Friendly Organisations, Dementia-Friendly Pharmacies, Healthy Lifestyles, Improving the Quality of Life for People with Long Term Conditions, Informal Carers, Information and Signposting Services, Integrated and Community-Based Care, Lifestyle Risk Factors, Long Term Conditions and Mental Health, Long-Term Conditions, Long-Term Conditions (LTCs), Long-Term Conditions and Dementia, MDTs: Multidisciplinary Teams, Medication Management, Medicines Adherence, Medicines Optimisation, Medicines Optimisation in Primary Care, Multidisciplinary Care, Multidisciplinary Team Care, Multidisciplinary Teamwork, Multiple Long-Term Conditions, NHS Community Pharmacy Contractual Framework (CPCF), NHS Community Pharmacy Contractual Framework (the Pharmacy Contract), Older Community-Dwelling Adults, Pharmacist-Led Home Medication Reviews, Pharmacy Quality Payments Scheme, Pharmacy: Aston University, Potentially Inappropriate Prescribing, Potentially Inappropriate Prescribing (PIP), Prevention, Prevention Agenda, Prevention of Avoidable Emergency Admissions: Proactive Management of Long-Term Conditions, Primary Care and Community Pharmacy Network, Proactive Management of Long-Term Conditions, Qualitative Exploratory Study, Qualitative Research, Qualitative Studies, Quality of Life for People With Long Term Conditions, Reducing Emergency Admissions Through Community-Based Interventions, School of Life and Health Sciences: Aston University, Self-Care, Self-Directed Support for Long Term Conditions, Self-Management, Self-Management Education, Self-Management in Chronic Illness, Self-Management in Early Stage Dementia, Self-Management of Long-Term Illnesses, Self-Management Support, Signposting, Signposting Patient Information, Signposting to Appropriate Health Services, Signposting to Sources of Practical Help, Support for Self-Care, Supporting Self-Care, University of East Anglia, University of Hull, Unmet Needs of Community-Dwelling Older Persons, Unpaid Carers | Leave a comment

Reducing Under-Usage of Medications (British Journal of Clinical Pharmacology)

Posted on June 22, 2017 by Dementia and Elderly Care News

Summary A meta-analysis investigating the impact of pharmaceutical care interventions for medication underuse in older people has shown that such interventions, including medication reviews, can reduce medication under-use in older people. Full Text Link Reference Meid, AD. Lampert, A. [and] … Continue reading →

Posted in Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, Systematic Reviews, Universal Interest | Tagged Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Ageing Population, Assessing Care of Vulnerable Elderly (ACOVE), Assessment of Underutilization (AOU) Index, British Journal of Clinical Pharmacology, Clinical Pharmacists, Community Pharmacists, Cooperation Unit Clinical Pharmacy: University of Heidelberg, Department of Clinical Pharmacology and Pharmacoepidemiology: University of Heidelberg, Germany, Good Prescribing, Medication Errors and Adverse Drug Reactions, Medication Reviews, Medication Underuse in Older People, Medication-Related Problems in the Elderly, Medications Under-Use, Optimisation of Pharmacotherapy in Older People, Pharmacist-Led Medication Reviews, Pharmacists, Polypharmacy in the Elderly STOPP and START Criteria, Potentially Inappropriate Prescribing (PIP), Reducing Under-Usage of Medications, School of Pharmacy: University of Colorado Anschutz Medical Campus, Screening Tool to Alert Doctors to Right Treatments (START), STOPP (Screening Tool of Older Person's Prescriptions), STOPP and START Criteria, Sub-Optimal Prescribing in Older Inpatients and Outpatients, Systematic Reviews and Meta-Analyses, Under-Usage of Medications, Undermedication, United States, University of Colorado, University of Heidelberg, USA | Leave a comment

Tag Archives: Potentially Inappropriate Prescribing (PIP)

Antidepressants Not Recommended for Depression in People With Dementia (NIHR Signal / Cochrane Database)

Management of BPSD in Alzheimer’s Disease (International Psychogeriatrics)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites